Latest News

This under-the-radar mining stock boasts a Superscore of 80 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

This electric air taxi stock is in recovery mode right now.

Opus Genetics (NASDAQ:IRD) outlined commercialization expectations for its newly approved presbyopia eye drop, progress across its inherited retinal disease gene therapy pipeline and its funding strategy during an investor panel featuring Chief Executive Officer Dr. George Magrath and Chief Financia

Monument Traders Alliance strategists detail a volatility-trading sleeve using IWM, QQQ and GLD options alongside longer-term holdings in Agnico Eagle Mines and Nuveen Municipal Value Fund for income.

The market has crashed before, and it'll probably happen again. So it's best to have a plan ready.

Tilray's transformation is still ongoing, but it just reached a critical milestone.

Musk just provided a mind-boggling 2027 revenue forecast for Space Exploration Technologies.

Netflix wants to claw back market share from YouTube, which has made considerable gains.

The earnings report and call were short on razzmatazz but long on substance, strengthening the investment case for the stock.

Neurocrine's expanding drug portfolio could drive substantial growth through 2031.

Deep Fission (NASDAQ:FISN) outlined its development, regulatory and financing plans for underground nuclear power projects during its October 2026 business update, targeting initial commercial power from a pilot project in Parsons, Kansas, by December 2027 and broader deployments beginning in 2028.

The company's third quarter was marked by double-digit growth.

Forecasts point to a high likelihood of continued gains, but possible headwinds could interrupt growth.

If things seem too perfect on Wall Street, they probably are.

For its stock to take off, Samsara must transform customer value into profitable growth.

The conglomerate bought back its shares in June for around $488 each. Are they still a buy at a record?

You might be able to turn that $10,000 into $115,347 -- or more. (Or less.)

The power of dollars compounding over 20 years can turn a small dividend income into a huge one.

Investing in just this one exchange-traded fund (ETF) for the past 25 years could have set you up for serious financial security.

The stock has been on a great run this year.

Adagene (NASDAQ:ADAG) is advancing its masked anti-CTLA-4 antibody, ADG126, also known as muzastotug, in metastatic microsatellite-stable colorectal cancer (MSS CRC) and in a neoadjuvant investigator-sponsored trial in Singapore, Chief Strategy Officer Mickael Chane-Du said during a Chardan conferen

Bloom Energy has benefited from tailwinds from data centers for power solutions. Here's what the company must do to continue delivering for investors.

Exceeding expectations on the bottom line can't compensate for this shortcoming -- at least in some investors' eyes.

Many AI stocks beat the Nasdaq Composite this year, and these three picks look like they can repeat the feat in 2027.

Earnings jumped 22% last fiscal year. Why would I still want the stock around 12% cheaper?